Category: Tech

https://www.creative-biolabs.com/car-t/adoptive-transfer-of-genetically-engineered-t-cells.htm ">adoptive transfer of genetically engineered T cell Over 400 clinical trials of CAR-T cell therapy are undergoing, but only two autologous CAR-T cell therapies (Kymriah™ and Yescarta™) were approved by the Food and Administration (FDA) and the Europe Union. Kymriah™ is for the treatment of pediatric patients and young adults with refractory or relapse (R/R) B cell precursor acute lymphoblastic leukemia, and Yescarta™ is for the treatment of adult patients with R/R large B cell lymphoma. In common, both are CD19-specific CAR-T cell therapies lysing CD19-positive targets.